Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
|
CN |
|
L
|
La Doria SpA
F:2DO
|
IT |
|
Sanken Electric Co Ltd
OTC:SANJF
|
JP |
|
Zhengzhou Qianweiyangchu Food Co Ltd
SZSE:001215
|
CN |
|
K
|
Kamux Oyj
OMXH:KAMUX
|
FI |
|
C
|
China CAMC Engineering Co Ltd
SZSE:002051
|
CN |
|
Shenzhen Rapoo Technology Co Ltd
SZSE:002577
|
CN |
|
Centum Electronics Ltd
NSE:CENTUM
|
IN |
|
Bioera SpA
MIL:BIE
|
IT |
|
E
|
Empower India Ltd
BSE:504351
|
IN |
|
Aisin Corp
TSE:7259
|
JP |
Wall Street
Price Targets
Price Targets Summary
Fujian Wanchen Biotechnology Co Ltd
According to Wall Street analysts, the average 1-year price target for
Fujian Wanchen Biotechnology Co Ltd
is 247.44 CNY
with a low forecast of 192.91 CNY and a high forecast of 289.8 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Fujian Wanchen Biotechnology Co Ltd's stock price target?
Price Target
247.44
CNY
According to Wall Street analysts, the average 1-year price target for
Fujian Wanchen Biotechnology Co Ltd
is 247.44 CNY
with a low forecast of 192.91 CNY and a high forecast of 289.8 CNY.
What is Fujian Wanchen Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
31%
For the last 10 years the
compound annual growth rate for
Fujian Wanchen Biotechnology Co Ltd's revenue is
73%.
The projected
CAGR
for the next 3 years is
31%.
What is Fujian Wanchen Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
56%
For the last 10 years the
compound annual growth rate for
Fujian Wanchen Biotechnology Co Ltd's operating income is
39%.
The projected
CAGR
for the next 4 years is
56%.
What is Fujian Wanchen Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
107%
For the last 10 years the
compound annual growth rate for
Fujian Wanchen Biotechnology Co Ltd's net income is
24%.
The projected
CAGR
for the next 3 years is
107%.
